We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$6.17B
AUM Growth
+$971M
Cap. Flow
+$684M
Cap. Flow %
11.08%
Top 10 Hldgs %
26.22%
Holding
1,261
New
68
Increased
1,018
Reduced
143
Closed
27

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$39.5M
2
AAPL icon
Apple
AAPL
+$38.5M
3
AMZN icon
Amazon
AMZN
+$20M
4
TSLA icon
Tesla
TSLA
+$12.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$11.6M

Sector Composition

Rank Sector Weight
1 Technology 27.46%
2 Healthcare 14.84%
3 Financials 12.1%
4 Consumer Discretionary 10.98%
5 Industrials 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABMD
1251
DELISTED
Abiomed Inc
ABMD
-9,359
Closed -$2.3M
SWCH
1252
DELISTED
Switch, Inc. Class A Common Stock
SWCH
-11,239
Closed -$379K
CLR
1253
DELISTED
CONTINENTAL RESOURCES INC.
CLR
-3,276
Closed -$219K
ZEN
1254
DELISTED
ZENDESK INC
ZEN
-14,449
Closed -$1.1M
TWTR
1255
DELISTED
Twitter, Inc.
TWTR
-139,101
Closed -$6.1M
AVLR
1256
DELISTED
Avalara, Inc.
AVLR
-10,312
Closed -$947K
Y
1257
DELISTED
Alleghany Corp
Y
-1,788
Closed -$1.5M
GBT
1258
DELISTED
Global Blood Therapeutics, Inc.
GBT
-3,624
Closed -$247K
DRE
1259
DELISTED
Duke Realty Corp.
DRE
-39,667
Closed -$1.91M
NLSN
1260
DELISTED
Nielsen Holdings plc
NLSN
-44,387
Closed -$1.23M
BHVN
1261
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-3,542
Closed -$535K

Similar funds

Xponance's Q4 2022 Portfolio in Review

As of Q4 2022, Xponance held 1,261 positions worth $6.17B, up 19% from $5.2B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Xponance deployed $684M of net new capital in Q4 2022, opening 68 new positions and adding to 1,018 existing holdings. Its largest new stake was Atlassian: 19,409 shares worth $2.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Everest Group, an estimated $1.58M trimmed.

  • Xponance's largest Q4 2022 buy was Atlassian: 19,409 shares worth $2.5M.
  • Xponance added most to Microsoft in Q4 2022, an estimated $39.5M increase.
  • Xponance's biggest Q4 2022 reduction was Everest Group, cutting an estimated $1.58M.
  • Xponance fully exited Twitter, Inc. in Q4 2022, selling an estimated $6.1M.
  • Xponance's ten largest holdings make up 26% of its $6.17B portfolio in Q4 2022.
  • Xponance opened 68 new positions and closed 27 in Q4 2022.
  • Xponance's portfolio value rose 19% quarter-over-quarter to $6.17B.

Based on Xponance's 13F filing for Q4 2022, filed 24 Jan 2023.